
18 year follow up study suggests high mortality risk from untreated sleep disordered breathing
Moderate-to-severe sleep apnea is independently associated with increased risk of mortality
Treatment of obstructive sleep apnea with CPAP may lower cardiovascular risk
A study found 16% of Australian commercial drivers suffer from obstructive sleep apnea and 60% have sleep-disordered breathing.
Read more about sleep disordered breathing.
S8 AutoSet Spirit™ II
Premium APAP device. Now with Easy-Breathe technology.
S8 Elite™ II
Premium CPAP device. Now with Easy-Breathe technology.
Mirage Activa™ LT
Experience the laws of attraction.
S8 Escape™ II
Standard CPAP device. Now with Easy-Breathe technology.

Swift™ LT
Light touch, Easy fit.
VPAP™ IV ST
Non-invasive bi-level pressure support. Compact, high performance.
International Diabetes Federation (IDF) makes statement supporting reciprocal screening of all patients with type 2 diabetes or sleep apnea.
Learn more about the link between OSA and type 2 diabetes.
To get the most out of your treatment, read our FAQs.
ResMed is a leading developer, manufacturer, and marketer of products for the diagnosis and treatment of sleep-disordered breathing.